2019
Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-beta
LI, J., M. RITELLI, C. S. MA, G. RAO, T. HABIB et. al.Základní údaje
Originální název
Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-beta
Autoři
LI, J. (840 Spojené státy), M. RITELLI (380 Itálie), C. S. MA (36 Austrálie), G. RAO (36 Austrálie), T. HABIB (634 Katar), E. CORVILAIN (250 Francie), S. BOUGARN (634 Katar), S. CYPOWYJ (840 Spojené státy), Lucie GRODECKÁ (203 Česká republika), R. LEVY (250 Francie), V. BEZIAT (250 Francie), L. SHANG (840 Spojené státy), K. PAYNE (36 Austrálie), D. T. AVERY (36 Austrálie), M. MIGAUD (250 Francie), S. BOUCHERIT (250 Francie), S. BOUGHORBEL (250 Francie), A. GUENNOUN (250 Francie), M. CHRABIEH (250 Francie), F. RAPAPORT (840 Spojené státy), B. BIGIO (840 Spojené státy), Y. ITAN (840 Spojené státy), B. BOISSON (250 Francie), V. CORMIER-DAIRE (250 Francie), D. SYX (56 Belgie), F. MALFAIT (56 Belgie), N. ZOPPI (380 Itálie), L. ABEL (250 Francie), Tomáš FREIBERGER (203 Česká republika, garant, domácí), H. C. DIETZ (840 Spojené státy), N. MARR (634 Katar), S. G. TANGYE (36 Austrálie), M. COLOMBI (380 Itálie), J. L. CASANOVA (250 Francie), A. PUEL (250 Francie) a C. FIESCHI
Vydání
SCIENCE IMMUNOLOGY, WASHINGTON, AMER ASSOC ADVANCEMENT SCIENCE, 2019, 2470-9468
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30102 Immunology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 13.440
Kód RIV
RIV/00216224:14110/19:00108609
Organizační jednotka
Lékařská fakulta
UT WoS
000516638800006
Klíčová slova anglicky
GROWTH-FACTOR-BETA; EHLERS-DANLOS-SYNDROME; OF-FUNCTION MUTATIONS; NH2-TERMINAL KINASE (JNK)1; INBORN-ERRORS; EXTRACELLULAR-MATRIX; CELL-DIFFERENTIATION; AORTIC-ANEURYSMS; STAT1 MUTATIONS; MARFAN-SYNDROME
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 6. 4. 2020 13:19, Mgr. Tereza Miškechová
Anotace
V originále
Genetic etiologies of chronic mucocutaneous candidiasis (CMC) disrupt human IL-17A/F-dependent immunity at mucosal surfaces, whereas those of connective tissue disorders (CTDs) often impair the TGF-beta-dependent homeostasis of connective tissues. The signaling pathways involved are incompletely understood. We report a three-generation family with an autosomal dominant (AD) combination of CMC and a previously undescribed form of CTD that clinically overlaps with Ehlers-Danlos syndrome (EDS). The patients are heterozygous for a private splice-site variant of MAPK8, the gene encoding c-Jun N-terminal kinase 1 (JNK1), a component of the MAPK signaling pathway. This variant is loss-of-expression and loss-of-function in the patients' fibroblasts, which display AD JNK1 deficiency by haploinsufficiency. These cells have impaired, but not abolished, responses to IL-17A and IL-17F. Moreover, the development of the patients' TH17 cells was impaired ex vivo and in vitro, probably due to the involvement of JNK1 in the TGF-beta-responsive pathway and further accounting for the patients' CMC. Consistently, the patients' fibroblasts displayed impaired JNK1- and c-Jun/ATF-2-dependent induction of key extracellular matrix (ECM) components and regulators, but not of EDS-causing gene products, in response to TGF-beta. Furthermore, they displayed a transcriptional pattern in response to TGF-beta different from that of fibroblasts from patients with Loeys-Dietz syndrome caused by mutations of TGFBR2 or SMAD3, further accounting for the patients' complex and unusual CTD phenotype. This experiment of nature indicates that the integrity of the human JNK1-dependent MAPK signaling pathway is essential for IL-17A- and IL-17F-dependent mucocutaneous immunity to Candida and for the TGF-beta-dependent homeostasis of connective tissues.
Návaznosti
NV16-34414A, projekt VaV |
|